Emerging treatment helps reverse chronic heart failure: Circulation study Dr. Kamal Kant Kohli26 Oct 2020 6:00 PM ISTResearchers have found in a prospective multicenter non-randomized study (RESTAGE-HF) that an emerging heart failure treatment could potentially...
Empagliflozin may reduce hospitalization and death risk in heart failure: Study Dr Satabdi Saha26 Oct 2020 8:00 AM ISTAccording to a recent research, patients receiving empagliflozin therapy for heart failure, showed a lower risk of cardiovascular death or...
Empagliflozin lowers death risk in HF in non Diabetics also: NEJM Medha Baranwal17 Oct 2020 10:30 AM ISTUSA: The use of SGLT2 inhibitor empagliflozin in heart failure patients lowers the risk of cardiovascular death and hospitalization for...
Beta Blockers reduce Mortality in Heart Failure Patients with CKD, claims study Dr Kartikeya Kohli13 Oct 2020 11:05 AM ISTCurrent national guidelines recommend that clinicians treat patients with heart failure and left ventricular systolic dysfunction with β-adrenergic...
Admission serum chloride levels prognostic markers for Heart failure, finds study. Dr.Niharika Harsha B12 Oct 2020 10:00 AM ISTRecent studies have shown that lower serum chloride level is associated with diuretic resistance and increased mortality in heart failure. Impact of...
SGLT2 inhibitors improve survival and renal outcomes in heart failure: Lancet Medha Baranwal16 Sept 2020 7:50 AM ISTFrance: Treatment with empagliflozin and dapagliflozin reduces all-cause mortality and improves renal outcomes in patients with heart failure with...
Dapagliflozin reduces hyperkalaemia risk in heart failure with reduced EF: Study Dr Satabdi Saha11 Sept 2020 1:15 PM ISTPatients with heart failure and reduced ejection fraction (HFrEF) and taking a mineralocorticoid receptor antagonists (MRA) who were randomized to...
PARALLAX meets one primary endpoint in heart failure with preserved ejection fraction Hina Zahid8 Sept 2020 11:20 AM ISTSophia Antipolis, France - Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does...
DCGI green flag to Abbott heart failure, angina treatment drug Ivabradine Farhat Nasim3 Sept 2020 4:54 PM ISTAbbott plans to launch Ivabradine prolonged-release tablets in the Indian market in the coming weeks.
ESC update: Empagliflozin Cuts risk of Hospitalization, CV Mortality in HFrEF: EMPEROR Hina Zahid29 Aug 2020 11:45 AM ISTSophia Antipolis, France - Empagliflozin is second SGLT2 inhibitor after dapagliflozin to show a significant benefit in the treatment of reduced...
Vaccines against respiratory infections cut heart failure deaths: ESC study Hina Zahid29 Aug 2020 10:17 AM ISTSophia Antipolis, France: Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That's the...
Sarcoidosis linked to Risk of Heart Failure, claims study Dr Satabdi Saha16 Aug 2020 9:04 PM ISTAccording to a recent study by the national Danish health data Patients with sarcoidosis had elevated long-term risk of adverse cardiac events as...
